Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (47 ops.)
Latest filing published 13 Dec 2018 for KERYX BIOPHARMACEUTICALS INC.
Insider track record
Disclosed buys
0
Disclosed sells
47
Signal history
No signal scores available.
Daniel Paul Regan: trading record in brief
Daniel Paul Regan discloses dealings in 2 companies, chiefly Intercept Pharmaceuticals, Inc. and Keryx Biopharmaceuticals Inc. The record holds 58 filings, for trades running from 5 March 2014 to 12 December 2018.
The open-market record consists of 47 sales worth €10.1M, with no purchase. The rest of the record consists of 6 share grants and 4 option exercises.
The latest filing, published on 13 December 2018, reports a transaction in Keryx Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel Paul Regan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
60,000 sharesCommon StockSEC:0000899243-18-030888:0
10,000 shares0Common StockSEC:0001114220-18-000075:0
10,000 shares0Common StockSEC:0000899243-17-016759:0
10,000 shares0Common StockSEC:0000899243-16-021128:0
10,000 shares0Common StockSEC:0001209191-15-054839:0
9,847 shares@ US$37.69Common StockSEC:0001144204-15-005703:0
6,847 shares@ US$200.07Common StockSEC:0001144204-15-005703:1
1,207 shares@ US$201.50Common StockSEC:0001144204-15-005703:2
793 shares@ US$202.49Common StockSEC:0001144204-15-005703:3
800 shares@ US$205.87Common StockSEC:0001144204-15-005703:4
200 shares@ US$208.08Common StockSEC:0001144204-15-005703:5
146 shares@ US$176.49Common StockSEC:0001144204-15-001258:0
8,124 shares@ US$37.69Common StockSEC:0001144204-14-050902:0
200 shares@ US$305.39Common StockSEC:0001144204-14-050902:1
100 shares@ US$306.91Common StockSEC:0001144204-14-050902:2
500 shares@ US$310.10Common StockSEC:0001144204-14-050902:3
500 shares@ US$311.89Common StockSEC:0001144204-14-050902:4
200 shares@ US$312.78Common StockSEC:0001144204-14-050902:5
800 shares@ US$313.84Common StockSEC:0001144204-14-050902:6
600 shares@ US$314.93Common StockSEC:0001144204-14-050902:7
200 shares@ US$316.62Common StockSEC:0001144204-14-050902:8
400 shares@ US$317.71Common StockSEC:0001144204-14-050902:9
400 shares@ US$319.47Common StockSEC:0001144204-14-050902:10
200 shares@ US$321.44Common StockSEC:0001144204-14-050902:11
100 shares@ US$322.92Common StockSEC:0001144204-14-050902:12
25 of 58 declarations
